Project Grant K99CA293336
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$161K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This federal Project Grant award of $692,417 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support research to investigate accelerated cardiac aging in adolescent and young adult (AYA) cancer survivors. The research aims to elucidate and define the accelerated cardiac aging phenotype in a diverse population of AYA cancer survivors, as well as identify predictors of this phenotype including factors such as race/ethnicity, genetic ancestry, social...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support a pilot study to explore the relationship between multi-level stressors, inflammation, and health-related quality of life (HRQOL) among long-term breast cancer survivors from different racial, ethnic, and nativity backgrounds. The $396,543 award, effective June 1, 2024 through May 31, 2026, will enable researchers at The Leland Stanford Junior University to collect survey data on...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, provides $664,259 to Duke University to develop and evaluate an accessible digital health intervention called AYA STEPS. The intervention aims to enhance symptom management and improve engagement with post-treatment healthcare for adolescent and young adult (AYA) cancer survivors. The award supports a randomized controlled trial to assess the efficacy of the...
This Project Grant, awarded by the National Cancer Institute (NCI) under the federal Cancer Cause and Prevention Research program (CFDA 93.393), will support the development and evaluation of a tailored mobile intervention, the "PERCS-YA" tool, to reduce worry and distress among young adult cancer survivors. The $290,052 award to the Regents of the University of Michigan will fund stakeholder engagement, intervention refinement, and a Phase II efficacy trial utilizing...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $699,517 to Wake Forest University Health Sciences to address financial hardship among adolescent and young adult (AYA) cancer survivors. The project aims to develop and test a multilevel intervention called FINFIT that combines educational, navigation, and resource coordination components to improve AYAs' health insurance literacy and reduce financial hardship. The...
This is a Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), totaling $1,239,420.00 and commencing on September 4, 2024. The award will fund a longitudinal observational study to assess changes in interoception (the brain's processing of internal bodily sensations) along the cancer chemotherapy continuum and its relationship to chemotherapy-induced peripheral neuropathy (CIPN) in 120 patients with breast...
This Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) provides $645,910 in funding to the Trustees of Indiana University (Indiana University Indianapolis) to conduct a study evaluating the efficacy of a telephone-based Acceptance and Commitment Therapy (ACT) intervention for advanced gastrointestinal cancer patients with fatigue interference and their family caregivers. The project aims to definitively examine the impact of the ACT intervention on...
This $621,732 five-year Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, will fund a hybrid effectiveness-implementation trial at the Medical University of South Carolina (MUSC). The project aims to 1) assess the effectiveness of a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer, 2) gather information on...
This federal Project Grant award, provided by the National Institute of Nursing Research (NINR) under the Nursing Research program (CFDA 93.361), is supporting the development and pilot testing of a digital intervention called AYA-NAV. The intervention aims to address the financial toxicity and unmet health-related social needs experienced by adolescent and young adult (AYA) cancer survivors. The $922,186 grant, awarded on August 5, 2024, will fund a study to refine the AYA-NAV intervention to a...
The National Cancer Institute (NCI) awarded a $515,404 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the University of California, Los Angeles (UCLA) to conduct a Phase III randomized clinical trial evaluating two new digital versions of a mindfulness intervention for younger breast cancer survivors. The study aims to test the efficacy of the "Mindful Awareness Practices" (MAPS) intervention delivered via a live online program and a mobile app in reducing...